Belite Bio (BLTE) Price to Earnings (2022 - 2026)
Belite Bio (BLTE) Price to Earnings (2022 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | P/E |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.10 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -70,009.43 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 918.78 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -379.65 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 27.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 15.33 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 367.72 Bn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 38.55 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -27.26 |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 65.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 23, 2026 | 367.72 Bn |
| Jul 22, 2026 | 369.74 Bn |
| Jul 21, 2026 | 379.01 Bn |
| Jul 20, 2026 | 359.62 Bn |
| Jul 17, 2026 | 353.13 Bn |
| Jul 16, 2026 | 354.52 Bn |
| Jul 15, 2026 | 351.69 Bn |
| Jul 14, 2026 | 345.13 Bn |
| Jul 13, 2026 | 345.95 Bn |
| Jul 10, 2026 | 351.36 Bn |
| Jul 9, 2026 | 360.56 Bn |
| Jul 8, 2026 | 358.35 Bn |
| Jul 7, 2026 | 371.04 Bn |
| Jul 6, 2026 | 362.40 Bn |
| Jul 2, 2026 | 345.01 Bn |
| Jul 1, 2026 | 334.85 Bn |
| Jun 30, 2026 | 362.33 Bn |
| Jun 29, 2026 | 363.88 Bn |
| Jun 26, 2026 | 349.95 Bn |
| Jun 25, 2026 | 352.54 Bn |